B16 cell lysates expressing the APOBEC3B-altered CSDE1 peptide, but not the wild-type peptide, enhanced survival of tumor bearing mice when combined with ICB, although less effectively than the APOBEC3B-modified cell vaccine, highlighting the advantage of a wide spectrum library approach63. The gene discussed is CSDE1; the disease is neoplasm.